Redirecting to original paper in 30 seconds...

Click below to go immediately or wait for automatic redirect

arxiv_ml 85% Match Research Paper Computational chemists,Drug discovery scientists,Structural biologists,Machine learning researchers in life sciences 1 week ago

Pearl: A Foundation Model for Placing Every Atom in the Right Location

generative-ai › diffusion
📄 Abstract

Abstract: Accurately predicting the three-dimensional structures of protein-ligand complexes remains a fundamental challenge in computational drug discovery that limits the pace and success of therapeutic design. Deep learning methods have recently shown strong potential as structural prediction tools, achieving promising accuracy across diverse biomolecular systems. However, their performance and utility are constrained by scarce experimental data, inefficient architectures, physically invalid poses, and the limited ability to exploit auxiliary information available at inference. To address these issues, we introduce Pearl (Placing Every Atom in the Right Location), a foundation model for protein-ligand cofolding at scale. Pearl addresses these challenges with three key innovations: (1) training recipes that include large-scale synthetic data to overcome data scarcity; (2) architectures that incorporate an SO(3)-equivariant diffusion module to inherently respect 3D rotational symmetries, improving generalization and sample efficiency, and (3) controllable inference, including a generalized multi-chain templating system supporting both protein and non-polymeric components as well as dual unconditional/conditional modes. Pearl establishes a new state-of-the-art performance in protein-ligand cofolding. On the key metric of generating accurate (RMSD < 2 \r{A}) and physically valid poses, Pearl surpasses AlphaFold 3 and other open source baselines on the public Runs N' Poses and PoseBusters benchmarks, delivering 14.5% and 14.2% improvements, respectively, over the next best model. In the pocket-conditional cofolding regime, Pearl delivers $3.6\times$ improvement on a proprietary set of challenging, real-world drug targets at the more rigorous RMSD < 1 \r{A} threshold. Finally, we demonstrate that model performance correlates directly with synthetic dataset size used in training.
Authors (40)
Genesis Research Team
Alejandro Dobles
Nina Jovic
Kenneth Leidal
Pranav Murugan
David C. Williams
+34 more
Submitted
October 28, 2025
arXiv Category
cs.LG
arXiv PDF

Key Contributions

Introduces Pearl, a foundation model for protein-ligand cofolding that addresses key challenges in structure prediction. It utilizes large-scale synthetic data, SO(3)-equivariant diffusion modules for inherent 3D symmetry, and improved architectures to predict accurate and physically valid protein-ligand complex structures at scale.

Business Value

Significantly accelerates the drug discovery pipeline by enabling faster and more accurate prediction of how drug candidates bind to target proteins. Reduces R&D costs and time-to-market for new therapeutics.